DnB Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.98M Hold
23,498
0.01% 482
2026
Q1
$4.61M Buy
23,498
+969
+4% +$188K 0.02% 456
2025
Q4
$3.91M Buy
22,529
+1,696
+8% +$309K 0.01% 496
2025
Q3
$3.97M Sell
20,833
-553
-3% -$98.1K 0.01% 476
2025
Q2
$3.84M Buy
21,386
+2,015
+10% +$350K 0.02% 444
2025
Q1
$3.28M Buy
19,371
+5
+0% +$821 0.02% 461
2024
Q4
$2.92M Buy
19,366
+451
+2% +$70.1K 0.01% 505
2024
Q3
$2.94M Sell
18,915
-387
-2% -$57.8K 0.01% 506
2024
Q2
$2.64M Sell
19,302
-12,491
-39% -$1.71M 0.01% 491
2024
Q1
$4.23M Sell
31,793
-5,308
-14% -$689K 0.02% 383
2023
Q4
$5.12M Sell
37,101
-28,631
-44% -$3.76M 0.03% 360
2023
Q3
$8.01M Sell
65,732
-16,653
-20% -$2.22M 0.05% 262
2023
Q2
$11.6M Sell
82,385
-10,452
-11% -$1.44M 0.07% 214
2023
Q1
$13.1M Sell
92,837
-1,769
-2% -$253K 0.08% 183
2022
Q4
$14.8M Sell
94,606
-2,203
-2% -$317K 0.1% 170
2022
Q3
$11.9M Buy
96,809
+2,620
+3% +$345K 0.09% 187
2022
Q2
$12.5M Buy
94,189
+11,141
+13% +$1.52M 0.09% 193
2022
Q1
$11.4M Buy
83,048
+5,765
+7% +$804K 0.07% 213
2021
Q4
$13.4M Sell
77,283
-32,390
-30% -$4.93M 0.08% 198
2021
Q3
$15.9M Sell
109,673
-6,498
-6% -$951K 0.1% 168
2021
Q2
$15.3M Buy
116,171
+20,367
+21% +$2.67M 0.1% 163
2021
Q1
$12.3M Sell
95,804
-52,088
-35% -$6.42M 0.09% 176
2020
Q4
$17.6M Sell
147,892
-18,112
-11% -$2.21M 0.15% 126
2020
Q3
$19M Buy
166,004
+83,263
+101% +$9.84M 0.2% 90
2020
Q2
$9.43M Sell
82,741
-85,277
-51% -$9.04M 0.11% 142
2020
Q1
$13.5M Buy
168,018
+139,416
+487% +$14.4M 0.2% 98
2019
Q4
$3.05M Sell
28,602
-75,201
-72% -$7.84M 0.03% 354
2019
Q3
$11.1M Sell
103,803
-5,971
-5% -$613K 0.13% 133
2019
Q2
$11.2M Buy
109,774
+94,551
+621% +$9.09M 0.13% 128
2019
Q1
$1.37M Sell
15,223
-2,443
-14% -$212K 0.02% 489
2018
Q4
$1.47M Sell
17,666
-1,670
-9% -$157K 0.02% 457
2018
Q3
$2.09M Buy
19,336
+700
+4% +$76.8K 0.02% 395
2018
Q2
$2.05M Sell
18,636
-63,800
-77% -$6.65M 0.02% 385
2018
Q1
$8.27M Sell
82,436
-14,200
-15% -$1.45M 0.1% 152
2017
Q4
$9.52M Buy
96,636
+79,700
+471% +$7.56M 0.11% 132
2017
Q3
$1.59M Hold
16,936
0.02% 397
2017
Q2
$1.88M Buy
16,936
+900
+6% +$95.2K 0.03% 340
2017
Q1
$1.57M Buy
16,036
+2,700
+20% +$257K 0.02% 382
2016
Q4
$1.23M Buy
13,336
+100
+0.8% +$8.62K 0.02% 384
2016
Q3
$1.12M Buy
13,236
+400
+3% +$33.6K 0.02% 382
2016
Q2
$1.04M Buy
12,836
+200
+2% +$15.2K 0.02% 374
2016
Q1
$903K Buy
+12,636
New +$847K 0.02% 406
2015
Q4
Sell
-35,536
Closed -$2.18M 467
2015
Q3
$2.18M Sell
35,536
-28,500
-45% -$1.99M 0.05% 209
2015
Q2
$4.64M Sell
64,036
-22,900
-26% -$1.69M 0.1% 152
2015
Q1
$6.68M Buy
86,936
+65,200
+300% +$4.67M 0.15% 127
2014
Q4
$1.46M Buy
21,736
+8,300
+62% +$524K 0.03% 287
2014
Q3
$815K Buy
13,436
+300
+2% +$18.5K 0.02% 363
2014
Q2
$771K Buy
+13,136
New +$769K 0.02% 374
2013
Q4
$1.2M Sell
22,436
-8,100
-27% -$480K 0.03% 222
2013
Q3
$1.89M Sell
30,536
-9,700
-24% -$581K 0.05% 151
2013
Q2
$2.44M Buy
+40,236
New +$2.4M 0.07% 126

Other funds holding DGX

DnB Asset Management's DGX Position: Q2 2026 in Review

DnB Asset Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 23,498 shares worth $4.98M. The position accounts for 0.01% of the portfolio, ranked #482.

DnB Asset Management first reported a position in DGX in Q2 2013 and has held it in 51 quarters since. The position peaked at $19M in Q3 2020. 802 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • DnB Asset Management held 23,498 shares of Quest Diagnostics worth $4.98M as of Q2 2026.
  • DnB Asset Management left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.01% of DnB Asset Management's portfolio in Q2 2026, its #482 holding.
  • DnB Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 51 quarters since.
  • DnB Asset Management's Quest Diagnostics position peaked at $19M in Q3 2020.
  • 802 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.